Curcumol inhibits the malignant progression of prostate cancer and regulates the PDK1/AKT/mTOR pathway by targeting miR‑9-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Curcumol inhibits the malignant progression of prostate cancer and regulates the PDK1/AKT/mTOR pathway by targeting miR‑9

Published:2021-09-28 Issue:5 Volume:46 Page:
ISSN:1021-335X
Container-title:Oncology Reports
language:
Short-container-title:Oncol Rep

Author:

Sheng Wen¹,Xu Wenjing²,Ding Jin³,Li Ling⁴,You Xujun³,Wu Yongrong¹,He Qinghu¹

Affiliation:

1. Andrology Laboratory, Hunan University of Chinese Medicine, Changsha, Hunan 410208, P.R. China

2. Dermatology Department, The First Hospital of Hunan University of Chinese Medicine, Changsha, Hunan 410021, P.R. China

3. Andrology Clinic, Shenzhen Baoan Hospital of Traditional Chinese Medicine, Shenzhen, Guangdong 518133, P.R. China

4. Medical Basic Teaching Experiment Center, Hunan University of Chinese Medicine, Changsha, Hunan 410208, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology,General Medicine

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dextran sulfate inhibits proliferation and metastasis of human gastric cancer cells via miR-34c-5p;Heliyon;2024-08

2. Icaritin-curcumol activates CD8+ T cells through regulation of gut microbiota and the DNMT1/IGFBP2 axis to suppress the development of prostate cancer;Journal of Experimental & Clinical Cancer Research;2024-05-23

3. Icariin‑curcumol promotes ferroptosis in prostate cancer cells through Nrf2/HO‑1 signaling;Experimental and Therapeutic Medicine;2024-03-26

4. Curcumol: a review of its pharmacology, pharmacokinetics, drug delivery systems, structure–activity relationships, and potential applications;Inflammopharmacology;2024-03-23

5. Curcumol Attenuates Portal Hypertension and Collateral Shunting Via Inhibition of Extrahepatic Angiogenesis in Cirrhotic Rats;Biochemical Genetics;2024-03-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3